CALS-Affiliate, Kenneth S. Kosik, speaks about current progress of Alzheimer’s treatment
Despite recent FDA approval of multiple pharmacologic treatments, Dr. Kosik says we “still have a long way to go.”
September 21, 2023
Dr. Kosik shares his expertise on the newest directions of Alzheimer’s research in the event “Keeping Pace with the Rapid Advances in Alzheimer’s”. By focusing on the genetic origins of Alzheimer’s, Dr. Kosik aims to find ways to interrupt formation of tau and amyloid beta plaques that are widely known to wreak havoc on the brain and lead to Alzheimer’s disease.
Related Links
